Isotretinoin Orifarm (Isotretinoin)

Isotretinoin binds to retinoic acid receptors in the nucleus of skin cells, altering gene expression to shrink sebaceous glands, lower sebum output, normalize follicular keratinization, and reduce inflammation, which together diminish acne lesion formation.

The specific dose of isotretinoin is determined by the prescribing clinician based on the patient’s weight, severity of acne, and tolerance. Dosage regimens are individualized and should follow the prescriber’s instructions.

Isotretinoin is classified as Pregnancy Category X and is contraindicated in pregnancy due to a high risk of severe birth defects. It is also not recommended while breastfeeding because it can be excreted in milk and affect the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Unlike topical agents or oral antibiotics, isotretinoin is a systemic retinoid that targets the underlying pathophysiology of severe acne, offering higher cure rates but with a distinct safety profile that requires careful monitoring.

Store the product below 25°C in its original packaging, protecting it from moisture and direct light. Keep the container tightly closed and out of reach of children.

Isotretinoin Orifarm is taken orally, usually with a meal to improve absorption. The exact administration schedule, including frequency and duration, is set by the prescribing healthcare professional.

The most serious risks include teratogenicity, severe depression or suicidal thoughts, inflammatory bowel disease, pseudotumor cerebri, and significant elevations in liver enzymes or triglycerides, all of which require prompt medical attention.

Isotretinoin should not be used by pregnant women, individuals planning pregnancy without reliable contraception, breastfeeding mothers, patients with uncontrolled hyperlipidaemia, severe liver disease, or those with a history of severe psychiatric disorders unless closely monitored.